Recanalization of Chronically Occluded Aorto-Coronary Saphenous Vein Bypass Grafts With Long-Term, Low Dose Direct Infusion of Urokinase Trial - ROBUST


ROBUST was a multicenter study designed to investigate the short-term efficacy and safety of a prolonged, low-dose, intragraft infusion of urokinase for the recanalization of chronically occluded saphenous vein bypass grafts.